Navigation Links
Richard T. Crowder Joins Neogen's Board of Directors
Date:11/23/2009

LANSING, Mich., Nov. 23 /PRNewswire-FirstCall/ -- Neogen Corporation (Nasdaq: NEOG) announced today that Richard T. Crowder, Ph.D., was elected to Neogen's Board of Directors at the company's recent annual meeting of shareholders.

Crowder has more than 40 years of experience in the food, agriculture, and trade industries and currently serves as an adjunct professor of agricultural economics at Virginia Tech University. From January 2006 until May 2007, he served as United States chief agriculture negotiator with the rank of ambassador.

"Since our founding in 1982, a strength of Neogen has been the quality of individuals on our Board of Directors, and the addition of Dr. Crowder certainly continues that tradition," said James Herbert, Neogen's chief executive officer and chairman. "Our Board provides valuable oversight, advice and support to senior management, not just during scheduled meetings, but throughout the year as we respond to the rapidly changing business environment."

Prior to his appointment as ambassador, Crowder served as chief executive officer of the American Seed Trade Association from 2002 to 2006, for five years as senior vice president of international affairs for DEKALB Genetics Corp. (later acquired by Monsanto), and for two years as executive vice president of Armour-Swift-Eckrich. He was appointed by President George H. W. Bush to serve from 1989 until 1992 as Undersecretary of the United States Department of Agriculture responsible for international affairs and commodity programs.

"With a wealth of experience in agriculture, international trade, and all aspects of the food industry, there are few people as qualified as Dr. Crowder to serve on our Board," said Lon Bohannon, Neogen's president. "We are pleased to have a person of Dr. Crowder's caliber to help Neogen build upon
'/>"/>

Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Richard Gephardt Joins Leading Innovators in Washington State to Call for Greater Focus on Policies to Boost Economy and Maintain U.S. Competitiveness in Medical Science and Innovation
2. Senator Arlen Specter and Richard Gephardt Headline Policy Forum on U.S. Medical Innovation, Highlight Achieving Recovery Through Discovery
3. Richard Giltner Joins United Therapeutics Board of Directors
4. Artemis Health Hires Richard Rava, Ph.D., as Senior Vice President of Research and Development
5. Franklin & Seidelmann Adds Richard Dyke to Senior Management Team as Senior VP, Sales/Marketing
6. Sir Richard Sykes Joins BioCeramic Therapeutics as Chairman
7. Trusted LASIK Surgeons Welcomes Mobile Alabama Expert Refractive Eye Surgeon Richard Duffey, M.D. to Its LASIK Directory For Consumers
8. Abt Associates Names Richard Small Vice President and Chief Financial Officer
9. Cytochroma Appoints R. Richard Wieland II As CFO
10. Richard A. Schatz, M.D. Joins Cardiums Scientific Advisory Board
11. Mr. Richard Decker Appointed Technical Director of Edgewood Chemical Biological Center
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... SAN DIEGO , May 5, 2015 /PRNewswire/ ... today announced that David R. Parkinson , ... (NEA), has been appointed to the board of ... twenty years of experience in oncology clinical development, ... that resulted in global approvals of the cancer ...
(Date:5/5/2015)... 2015 GEA Pharma Systems, G-CON ... recipients of the INTERPHEX Exhibitor Awards for 2015 ... Portable, Continuous, Miniature and Modular (PCMM) platform. PCMM ... continuous processing equipment, smart control systems and PODs ... and inactive ingredients into bulk tablets. , ...
(Date:5/5/2015)... CA (PRWEB) May 05, 2015 Synedgen ... Nguyen, PhD as Regulatory Affairs Manager. , Dr. Nguyen ... an important juncture for the company as it moves ... drug products over the next two years. Dr. Nguyen ... of all the regulatory key documents that must be ...
(Date:5/4/2015)... , May 4, 2015 Many of ... But for certain infants with rare, inherited mutations ... stark consequences of their impaired immune responses. ... have identified an important role for calcium signaling ... Mycobacterium tuberculosis, the bacterium causing tuberculosis (TB). ...
Breaking Biology Technology:Tocagen Appoints David R. Parkinson, M.D., to the Board of Directors 2Tocagen Appoints David R. Parkinson, M.D., to the Board of Directors 3Tocagen Appoints David R. Parkinson, M.D., to the Board of Directors 4GEA Pharma Systems, G-CON Manufacturing and Pfizer Consortium Receives Best Technology Innovation Award at INTERPHEX 2015 2GEA Pharma Systems, G-CON Manufacturing and Pfizer Consortium Receives Best Technology Innovation Award at INTERPHEX 2015 3Synedgen Announces the Appointment of Regulatory Affairs Manager 2Researchers Discover A Novel And Unexpected Role For Calcium In Controlling Inflammation During Chronic Lung Infection 2Researchers Discover A Novel And Unexpected Role For Calcium In Controlling Inflammation During Chronic Lung Infection 3
... 28 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc.,("Oncolytics") (TSX:ONC, ... interim results from a U.K. Phase Ia/Ib ... with advanced or,metastatic cancers is scheduled to ... (NCRI) conference on October 2, 2007 in ...
... Limited (NasdaqCM: PRAN) (ASX: PBT.AX), a biopharmaceutical,company ... treatments for,neurodegenerative disorders, today announced it has ... statements for the year ended,June 30, 2007, ... The annual,report its available on Prana,s website ...
... VaxGen,Inc. (Pink Sheets: VXGN) announced today that ... Directors as a result of accepting the CEO,position ... that Mr.,Anthony relinquish all corporate directorships in accepting ... (Logo: http://www.newscom.com/cgi-bin/prnh/19991112/VAXGENLOGO ) "On behalf of ...
Cached Biology Technology:Oncolytics Biotech Inc. Reports Positive Interim Results of U.K. Phase Ia/Ib Combination REOLYSIN(R) and Radiation Clinical Trial 2Oncolytics Biotech Inc. Reports Positive Interim Results of U.K. Phase Ia/Ib Combination REOLYSIN(R) and Radiation Clinical Trial 3Oncolytics Biotech Inc. Reports Positive Interim Results of U.K. Phase Ia/Ib Combination REOLYSIN(R) and Radiation Clinical Trial 4Jack Anthony to Resign From VaxGen's Board After Accepting CEO Position at Osprey Pharmaceuticals 2
(Date:3/24/2015)... --Research and Markets ( http://www.researchandmarkets.com/research/hdgz7h/global_iris ) has ... Market 2015-2019" report to their offering. ... grow at a CAGR of 23.5 percent over the ... scenario and the growth prospects of the Global Iris ... market size, the report considers the revenue generated from ...
(Date:3/24/2015)... 24, 2015   Crossmatch ™, a leading ... that its U.are.U ® 4500 Fingerprint Readers ... Bros . to achieve PCI compliance for Point-of-Sale ... to the POS terminal, protecting the retailer and ... breaches. With one-third of worldwide ...
(Date:3/23/2015)... , March 23, 2015  In the 2014 fiscal ... case conviction losses. This figure accounts for a fraction ... to The Nilson Report, exceeds $11 billion globally. The ... after a crime has occurred. Investor Mark Saint ... expert Joe Paolella partnered to administer the ...
Breaking Biology News(10 mins):Global Iris Recognition Market 2015-2019 with 3M Cogent, Bioenable Technologies, Cross Match Technology, Iris ID Systems & Safran Dominating 2Crossmatch Fingerprint Readers Help Retailer Prevent Data Breaches at Point-of-Sale 2Polygraph Test Now Used to Protect Investors From Fraud 2Polygraph Test Now Used to Protect Investors From Fraud 3
... tissue-engineered trachea (windpipe), utilising the patient,s own stem ... woman with a failing airway. The bioengineered trachea ... airway, thereby saving her life. These ... stem cells, combined with biologically compatible materials, can ...
... breakthrough against cancer, infectious diseases, or metabolic conditions like ... drugs, and even if they do clinical development usually ... medical research is conducted in highly fragmented groups focusing ... turn out not to work properly or to have ...
... created by a University of Central Florida professor show ... Professor James Turkson,s compounds disrupt the formation and spread ... The compounds, S3I-201 and S3I-M2001, break up a cancer-causing ... side effects so far. "The compounds are very ...
Cached Biology News:Adult stem cell breakthrough 2Adult stem cell breakthrough 3Systems biology brings hope of speeding up drug development 2Systems biology brings hope of speeding up drug development 3Two new compounds show promise for eliminating breast cancer tumors 2
... tumor cells of embryonal carcinoma of testis and ... tumors like seminoma. Glandular epithelium of yolk sac ... endocrine cells of stomach and acini cells of ... Epitope: Carbohydrate portion on human embryonal ...
TP-1 (NDOG1)...
Ras-related C3 botulinum toxin substrate 1...
Mouse monoclonal [6G11] to Cytohesin 1 + 2 ( Abpromise for all tested applications)....
Biology Products: